Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses

• मुख्य लेखकों: Yizhou Wang (लेखक), Peipei Shang (लेखक), Chang Xu (लेखक), Wei Dong (लेखक), Xiaofeng Zhang (लेखक), Yong Xia (लेखक), Chengjun Sui (लेखक), Cheng Yang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Introduction: Genomic profiling has revolutionized therapeutic interventions and the clinical management of liver cancer. However, pathogenetic mechanisms, molecular determinants of recurrence, and predictive biomarkers for first-line treatment (anti-PD-(L)1 plus bevacizumab) in liver cancer remain...